BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28974441)

  • 1. Tyrosol attenuates lipopolysaccharide-induced acute lung injury by inhibiting the inflammatory response and maintaining the alveolar capillary barrier.
    Kim YY; Lee S; Kim MJ; Kang BC; Dhakal H; Choi YA; Park PH; Choi H; Shin TY; Choi HG; Kwon TK; Khang D; Kim SH
    Food Chem Toxicol; 2017 Nov; 109(Pt 1):526-533. PubMed ID: 28974441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methanol extract of Antrodia camphorata protects against lipopolysaccharide-induced acute lung injury by suppressing NF-κB and MAPK pathways in mice.
    Huang GJ; Deng JS; Chen CC; Huang CJ; Sung PJ; Huang SS; Kuo YH
    J Agric Food Chem; 2014 Jun; 62(23):5321-9. PubMed ID: 24849405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardamine komarovii flower extract reduces lipopolysaccharide-induced acute lung injury by inhibiting MyD88/TRIF signaling pathways.
    Chen Q; Zhang KX; Li TY; Piao XM; Lian ML; An RB; Jiang J
    Chin J Nat Med; 2019 Jun; 17(6):461-468. PubMed ID: 31262458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
    Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
    J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycyrrhizin treatment is associated with attenuation of lipopolysaccharide-induced acute lung injury by inhibiting cyclooxygenase-2 and inducible nitric oxide synthase expression.
    Ni YF; Kuai JK; Lu ZF; Yang GD; Fu HY; Wang J; Tian F; Yan XL; Zhao YC; Wang YJ; Jiang T
    J Surg Res; 2011 Jan; 165(1):e29-35. PubMed ID: 21074783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclareol ameliorate lipopolysaccharide-induced acute lung injury through inhibition of MAPK and induction of HO-1 signaling.
    Hsieh YH; Deng JS; Pan HP; Liao JC; Huang SS; Huang GJ
    Int Immunopharmacol; 2017 Mar; 44():16-25. PubMed ID: 28068646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soyasaponin Ab inhibits lipopolysaccharide-induced acute lung injury in mice.
    Lin J; Cheng Y; Wang T; Tang L; Sun Y; Lu X; Yu H
    Int Immunopharmacol; 2016 Jan; 30():121-128. PubMed ID: 26672918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shikonin attenuates lipopolysaccharide-induced acute lung injury in mice.
    Bai GZ; Yu HT; Ni YF; Li XF; Zhang ZP; Su K; Lei J; Liu BY; Ke CK; Zhong DX; Wang YJ; Zhao JB
    J Surg Res; 2013 Jun; 182(2):303-11. PubMed ID: 23158409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Licochalcone a inhibits lipopolysaccharide-induced inflammatory response in vitro and in vivo.
    Chu X; Ci X; Wei M; Yang X; Cao Q; Guan M; Li H; Deng Y; Feng H; Deng X
    J Agric Food Chem; 2012 Apr; 60(15):3947-54. PubMed ID: 22400806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of 2-cyano-3, 12-dioxooleana-1, 9(11)-en-28-oate-13β, 28-olide as a potent anti-inflammatory agent for intervention of LPS-induced acute lung injury.
    Mou Y; Jian YL; Chen T; Huang ZJ; Qiao YX; Peng SX; Zhang DY; Ji H; Zhang YH
    Chin J Nat Med; 2017 May; 15(5):347-354. PubMed ID: 28558870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginsenoside Rg5 ameliorates lung inflammation in mice by inhibiting the binding of LPS to toll-like receptor-4 on macrophages.
    Kim TW; Joh EH; Kim B; Kim DH
    Int Immunopharmacol; 2012 Jan; 12(1):110-6. PubMed ID: 22107725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of taraxasterol on acute lung injury induced by lipopolysaccharide in mice.
    San Z; Fu Y; Li W; Zhou E; Li Y; Song X; Wang T; Tian Y; Wei Z; Yao M; Cao Y; Zhang N
    Int Immunopharmacol; 2014 Apr; 19(2):342-50. PubMed ID: 24548765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total flavonoids of Mosla scabra leaves attenuates lipopolysaccharide-induced acute lung injury via down-regulation of inflammatory signaling in mice.
    Chen J; Wang JB; Yu CH; Chen LQ; Xu P; Yu WY
    J Ethnopharmacol; 2013 Jul; 148(3):835-41. PubMed ID: 23747643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naringin attenuates acute lung injury in LPS-treated mice by inhibiting NF-κB pathway.
    Liu Y; Wu H; Nie YC; Chen JL; Su WW; Li PB
    Int Immunopharmacol; 2011 Oct; 11(10):1606-12. PubMed ID: 21640201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acanthoic acid ameliorates lipopolysaccharide-induced acute lung injury.
    Qiushi W; Guanghua L; Guangquan X
    Eur J Pharmacol; 2015 Mar; 750():32-8. PubMed ID: 25620130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clausena anisata-mediated protection against lipopolysaccharide-induced acute lung injury in mice.
    Jeon CM; Shin IS; Shin NR; Hong JM; Kwon OK; Kim JH; Oh SR; Bach TT; Hai DV; Quang BH; Choi SH; Lee J; Myung PK; Ahn KS
    Int J Mol Med; 2016 Apr; 37(4):1091-8. PubMed ID: 26952971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginkgo biloba extracts attenuate lipopolysaccharide-induced inflammatory responses in acute lung injury by inhibiting the COX-2 and NF-κB pathways.
    Yao X; Chen N; Ma CH; Tao J; Bao JA; Zong-Qi C; Chen ZT; Miao LY
    Chin J Nat Med; 2015 Jan; 13(1):52-8. PubMed ID: 25660288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of acteoside on lipopolysaccharide-induced inflammation in acute lung injury via regulation of NF-κB pathway in vivo and in vitro.
    Jing W; Chunhua M; Shumin W
    Toxicol Appl Pharmacol; 2015 Jun; 285(2):128-35. PubMed ID: 25902336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stevioside protects LPS-induced acute lung injury in mice.
    Yingkun N; Zhenyu W; Jing L; Xiuyun L; Huimin Y
    Inflammation; 2013 Feb; 36(1):242-50. PubMed ID: 22968433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shikonin exerts anti-inflammatory effects in a murine model of lipopolysaccharide-induced acute lung injury by inhibiting the nuclear factor-kappaB signaling pathway.
    Liang D; Sun Y; Shen Y; Li F; Song X; Zhou E; Zhao F; Liu Z; Fu Y; Guo M; Zhang N; Yang Z; Cao Y
    Int Immunopharmacol; 2013 Aug; 16(4):475-80. PubMed ID: 23651796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.